1. Home
  2. MXL vs NNNN Comparison

MXL vs NNNN Comparison

Compare MXL & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MaxLinear Inc.

MXL

MaxLinear Inc.

HOLD

Current Price

$19.19

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$34.77

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MXL
NNNN
Founded
2003
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.5B
IPO Year
2010
2025

Fundamental Metrics

Financial Performance
Metric
MXL
NNNN
Price
$19.19
$34.77
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$20.25
N/A
AVG Volume (30 Days)
972.8K
37.0K
Earning Date
01-29-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.06
Revenue
$423,372,000.00
$6,920,153.00
Revenue This Year
$30.54
N/A
Revenue Next Year
$18.23
N/A
P/E Ratio
N/A
$668.91
Revenue Growth
7.53
N/A
52 Week Low
$8.35
$5.18
52 Week High
$25.73
$55.65

Technical Indicators

Market Signals
Indicator
MXL
NNNN
Relative Strength Index (RSI) 59.03 N/A
Support Level $17.90 N/A
Resistance Level $19.12 N/A
Average True Range (ATR) 0.77 0.00
MACD -0.03 0.00
Stochastic Oscillator 75.06 0.00

Price Performance

Historical Comparison
MXL
NNNN

About MXL MaxLinear Inc.

MaxLinear Inc is a provider of radio frequency and mixed-signal integrated circuits for cable and satellite broadband communications, the connected home, and for data center, metro, and long-haul fiber networks. The company's radio frequency receiver products capture and process digital and analog broadband signals to be decoded for various applications. Its product options include both radio frequency receivers and radio frequency receiver systems-on-chips. The company's products enable the distribution and display of broadband video and data content in a wide range of electronic devices.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: